,i #aafth ,,congress #ast ,session ,h4 ,r4 #cggb ,,in ,,the ,,house ,,of ,,representatives ,july #af1 #bjai ,mr4 ,peters 7for himself1 ,mr4 ,rush1 and ,mr4 ,holding7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to ensure equitable payment for1 and preserve ,medicare beneficiary access to1 diagnostic radiopharmaceuticals under the ,medicare hospital outpatient prospective payment system4 #a4 ,short title ,this ,act may be cited as the ,medicare ,diagnostic ,radiopharmaceutical ,payment ,equity ,act of #bjai4 #b4 ,separate payment for certain diagnostic radiopharmaceuticals 7a7 ,in general ,section #ahcc7t77#af7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciel7t77#af77 is amended by adding at the end the following new subparagraph3 7,g7 ,separate payment for certain diagnostic radiopharmaceuticals 7i7 ,in general ,notwithstanding any other provision of this subsection1 with respect to services furnished on or after ,january #a1 #bjbj1 the ,secretary shall not package1 and shall make a separate payment as specified in clause 7ii7 for1 a diagnostic radiopharmaceutical defined in clause 7v7 with an estimated mean per day product cost equal to or exceeding the threshold specified in clause 7iii74 7ii7 ,separate payment ,for purposes of clause 7i71 payment specified in this clause for a diagnostic radiopharmaceutical described in clause 7i7 shall be equal to-- 7,i7 the average sales price for the drug established under section #ahdg;,a1 to the extent the average sales price is available1 as calculated and adjusted by the ,secretary to the extent such adjustment is adopted for other specified covered outpatient drugs under paragraph 7#ad77;,a72 or 7,,ii7 if the data necessary to calculate the average sales price for the drug in the year under the sections specified in subclause 7,i7 is not available1 the wholesale acquisition cost as defined in subsection #ahdg;,a7c77#f77;,b71 or1 if the wholesale acquisition cost is not available1 the mean unit cost data derived from hospital claims data4 7,,iii7 ,nothing in this subparagraph shall be construed as affecting eligibility of diagnostic radiopharmaceuticals for pass-through payments under paragraph 7#f74 7iii7 ,threshold ,for purposes of this subparagraph1 the threshold specified in this clause-- 7,i7 for #bjbj1 is #ejj2 and 7,,ii7 for subsequent years1 is the amount specified in this clause for the preceding year increased by the percentage of the ,,opd fee schedule increase factor under paragraph 7#c77;,c77iv7 for the applicable year4 7iv7 ,budget neutrality ,the ,secretary shall make such adjustments as are necessary under subparagraph #i7;,b7 to ensure that the amount of expenditures under this subsection for such year with application of this subparagraph is equal to the amount of expenditures that would be made under this subsection for such year without application of this subparagraph4 7v7 ,definition ,for purposes of this subparagraph1 a diagnostic radiopharmaceutical is a drug or biological that is described in section #cae4b7;a7 of title #ba1 ,code of ,federal ,regulations1 or any successor regulation1 and is approved by the ,food and ,drug ,administration on or after ,january #a1 #bjjh4 4 7b7 ,no impact on copayment ,section #ahcc7t7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciel7t77#h77;,e77 is amended by-- 7#a7 inserting ,,and ,,separate ,,payments ,,for ,,certain ,,diagnostic ,,radiopharmaceuticals after ,,pass-,,through ,,adjustments2 and 7#b7 inserting after such adjustments7 the phrase and subparagraph 7#af77;,g74